Dendritic cells previously exposed to mannan-binding lectin enhance cytokine production in allogeneic mononuclear cell cultures

Human Immunology

Volumn 71, Issue 11, 2010, Pages 1077-1083

  MacDonald, Shirley L ^a   Downing, Ian ^a   Atkinson, Anne P M ^a   Gallagher, Ronald C J ^a   Turner, Marc L ^a   Kilpatrick, David C ^a  

^a SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

Author keywords

Dendritic cells; Mannan binding lectin; Mannose binding lectin

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; MANNAN BINDING LECTIN; MEMBRANE ANTIGEN; RECOMBINANT MANNAN BINDING LECTIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELLULAR IMMUNITY; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MONOCYTE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL;

CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; DENDRITIC CELLS; HUMANS; INFLAMMATION MEDIATORS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MANNOSE-BINDING LECTIN; MONOCYTES; RECOMBINANT PROTEINS;

EID: 77957751192     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2010.07.011     Document Type: Article

References (37)

1. Dubsky P., Ueno H., Piqueras B., Connolly J., Banchereau J., Palucka A.K. Human dendritic cell subsets for vaccination. J Clin Immunol 2005, 25:551-572.
2. Sato K., Fujita S. Dendritic cells-nature and classification. Allergol Int 2007, 56:183-191.
3. Waldner H. The role of innate immune responses in autoimmune disease development. Autoimmun Rev 2009, 8:400-404.
4. Peron J.P.S., de Oliveira A.P.L., Rizzo L.V. It takes guts for tolerance: The phenomenon of oral tolerance and the regulation of autoimmune response. Autoimmun Rev 2009, 9:1-4.
5. Brossart M.D.P. Dendritic cells in vaccination therapies of malignant diseases. Transfus Apheres Scientist 2002, 27:183-186.
6. Voss C.Y., Albertini M.R., Malter J.S. Dendritic cell-based immunotherapy for cancer and relevant challenges for transfusion medicine. Transfus Med Rev 2004, 18:189-202.
7. Morel P.A., Feili-Hariri M., Coates P.T., Thomson A.W. Dendritic cells, T cell tolerance and therapy of adverse immune reactions. Clin Exp Immunol 2003, 133:1-10.
8. Matasic R., Dietz A.B., Vuk-Pavlovic S. Cyclooxygenase-independent inhibition of dendritic cell maturation by aspirin. Immunology 2000, 101:53-60.
9. de Jong E.C., Vieira P.L., Kalinski P., Kapsenberg M.L. Corticosteroids inhibit the production of inflammatory mediators in immature monocyte-derived DC and induce the development of tolerogenic DC3. Leuk J Biol 1999, 66:201-204.
10. Lagaraine C., Lemoine R., Baron C., Nivet H., Velge-Roussel F., Lebranchu Y. Induction of human CD4 regulatory T cells by mycophenolic acid-treated dendritic cells. Leuk J Biol 2008, 84:1057-1064.
11. Tenner A.J. Membrane receptors for defense collagens. Curr Opin Immunol 1999, 11:34-42.
12. Kilpatrick D.C. Mannan-binding lectin: Clinical significance and applications. Biochim Biophys Acta 2002, 1572:401-413.
13. Kilpatrick D.C. Mannan-binding lectin and its role in innate immunity. Transfus Med 2002, 12:335-351.
14. Petersen K.A., Matthiesen F., Agger T., Kongerslev L., Thiel S., Cornelissen K., Axelsen M. Phase I safety, tolerability, and pharmacokinetic study of recombinant human mannan-binding lectin. J Clin Immunol 2002, 26:465-475.
15. Valdimarsson H. Infusion of plasma-derived mannan-binding lectin (MBL) into MBL-deficient humans. Biochem Soc Trans 2003, 31:768-769.
16. Mullighan C.G., Heatly S., Doherty K., Szabo F., Grigg A., Hughes T.P., et al. Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic stem cell transplantation. Blood 2002, 99:3524-3529.
17. Mullighan C.G., Heatly S.E., Danner S., Dean M., Doherty K.V., Hahn U., et al. Mannose-binding lectin status is associated with risk of major infection following myeloablative sibling allogeneic hematopoitic stem cell transplantation. Blood 2008, 112:2120-2128.
18. Kilpatrick D.C., Stewart K., Allan E.K., McLintock L.A., Holyoake T.L., Turner M.L. Successful haemopoietic stem cell transplantation does not correct mannan-binding lectin deficiency. Marrow B (Trans) 2005, 35:179-181.
19. Bouwman L.H., Roos A., Terpstra O.T., De Knijff P., Van Hoek B., Verspaget H.W., et al. Mannose binding lectin gene polymorphisms confer a major risk for severe infections after liver transplantation. Gastroenterologist 2005, 129:408-414.
20. Worthley D.L., Johnson D.F., Eisen D.P., Dean M.M., Heatley S.L., Tung J.-P., et al. Donor mannose-binding lectin deficiency increases the likelihood of clinically significant infection after liver transplantation. Clin Infect Dis 2009, 48:410-417.
21. Downing I., Koch C., Kilpatrick D.C. Immature dendritic cells possess a sugar-sensitive receptor for human mannan-binding lectin. Immunology 2003, 109:360-364.
22. Downing I., MacDonald S.L., Turner M.L., Kilpatrick D.C. Detection of an autologous ligand for mannan-binding lectin on human B lymphocytes. Scand J Immunol 2005, 62:507-514.
23. Kilpatrick D.C. Stem cell transplantation and MBL replacement therapy. Curr Stem Cell Res Ther 2008, 3:85-87.
24. Jensenius J.-C., Jensen P.H., McGuire K., Larsen J.L., Thiel S. Recombinant mannan-binding lectin (MBL) for therapy. Biochem Soc Trans 2003, 31:763-767.
25. + cells. Vox Sang 2010, 98:e290-e294.
26. Madsen H.O., Garred P., Kurtzhals J.A.L., Lamm L.U., Ryder L.P., Thiel S., Svejgaard A. A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein. Immunogenetics 1994, 40:37-44.
27. Swierzko A.S., Szala A., Cedzynski M., Domzalska-Popadiuk I., Borkowska-Klos M., Jopek A., et al. Mannan-binding lectin genotypes and genotype-phenotype relationships in a large cohort of Polish neonates. Hum Immunol 2009, 70:68-72.
28. Minchinson R.M., Dean M.M., Clark T.R., Heatley S., Mullighan C.G. Analysis of the relationship between mannose-binding lectin (MBL) genotype, MBL levels and function in an Australian blood donor population. Scand J Immunol 2002, 56:630-641.
29. Garred P., Larsen F., Madsen H.O., Koch C. Mannose-binding lectin deficiency-revisited. Mol Immunol 2003, 40:73-84.
30. Soell M., Lett E., Holveck F., Scholler M., Wachsmann D., Klein J.-P. Activation of human monocytes by streptococcal rhamnose glucose polymers is mediated by CD14 antigen, and mannan binding protein inhibits TNFα release. J Immunol 1995, 154:851-860.
31. Chaka W., Verheul A.F.M., Vaishnav V.V., Cherniak R., Scharringa J., Verhoef J., et al. Induction of TNFα in human peripheral blood mononuclear cells by the mannoprotein of Cryptococcus neoformans involves human mannose binding protein. J Immunol 1997, 159:2979-2985.
32. Jack D.L., Read R.C., Tenner A.J., Frosch M., Turner M.W., Klein N.J. Mannose-binding lectin regulates the inflammatory response of human professional phagocytes to Neisseria meningitides serogroup. Br J Infect Dis 2001, 184:1152-1162.
33. Heggelund L., Mollnes T.E., Espevik T., Muller F., Kristiansen K.I., Aukrust P., Froland S.S. Modulatory effect of mannose-binding lectin on cytokine responses: Possible roles in HIV infection. Eur J Clin Invest 2005, 35:765-770.
34. Garred P., Pressler T., Lanng S., Madsen H.O., Moser C., Laursen I., et al. Mannose-binding lectin (MBL) therapy in an MBL-deficient patient with severe cystic fibrosis lung disease. Pediatr Pulmonol 2002, 33:201-207.
35. Hornstein E., Shomron N. Canalization of development by microRNAs. Nat Genet 2006, 38:S20-S24.
36. Dean MM. Thesis 2009. University of Queensland.
37. Shimizu T., Nishitani C., Mitsuzawa H., Ariki S., Takahashi M., Ohtani K., et al. Mannose binding lectin and lung collectins interact with toll-like receptor 4 and MD-2 by different mechanisms. Biochim Biophys Acta 2009, 1790:1705-1710.